作者:George H. Cocolas、James M. Chapman、P. Josée Voorstad、Iris H. Hallx
DOI:10.1002/jps.2600720723
日期:1983.7
A series of substituted 2-pyrrolidinones was evaluated for hypolipidemic activity at 20 and 30 mg/kg/day in CF1 male mice. 4-Phenyl-5,5-dicarbethoxy-2-pyrrolidinone was the most potent compound at 30 mg/kg/day, reducing serum triglyceride levels 52% after 14 days of dosing and serum cholesterol levels 48% after 16 days of dosing. 4-Phenyl-5-carbethoxy-2-pyrrolidinone and 4-phenyl-3,5,5-tricarbethoxy-2-pyrrolidinone
在CF1雄性小鼠中,评估了一系列取代的2-吡咯烷酮在20和30 mg / kg / day时的降血脂活性。4-苯基-5,5-二甲乙氧基-2-吡咯烷酮是最有效的化合物,剂量为30 mg / kg / day,给药14天后血清甘油三酯水平降低52%,给药16天后血清胆固醇水平降低48%。4-苯基-5-甲乙氧基-2-吡咯烷酮和4-苯基-3,5,5-三甲乙氧基-2-吡咯烷酮也显示出显着的活性。那些含有苯基取代基的化合物比未取代的,烷基的或二碳乙氧基的2-吡咯烷酮类似物更有效。